Ansbert Gadicke Cullinan Oncology, Inc. (CGEM) insider trading activity
Ansbert Gadicke is Director of Cullinan Oncology, Inc.. Currently has a direct ownership of 244,551 shares of CGEM, which is worth approximately $4.22 Million. The most recent transaction as insider was on Sep 16, 2021, when has been sold 432 shares (Common Stock) at a price of $29.06 per share, resulting in proceeds of $12,554. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
245K
0%
3M change
0%
12M change
Total Value Held
$4.22 Million
ANSBERT GADICKE Transaction History
Also insider at
AG
Ansbert Gadicke
Director
Waltham, MA